Acotec Scientific Holdings Limited
HKEX:6669.HK
7.51 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 115.393 | 115.393 | 121.532 | 121.532 | 110.112 | 110.112 | 87.661 | 87.661 | 81.809 | 81.809 | 86.875 | 53.32 | 62.955 | 62.955 | 48.442 | 19.624 |
| Cost of Revenue
| 24.243 | 24.243 | 23.974 | 23.974 | 14.32 | 14.32 | 15.276 | 15.276 | 10.678 | 10.678 | 9.879 | 6.639 | 9.355 | 9.355 | 7.444 | 4.042 |
| Gross Profit
| 91.15 | 91.15 | 97.558 | 97.558 | 95.792 | 95.792 | 72.385 | 72.385 | 71.131 | 71.131 | 76.996 | 46.681 | 53.6 | 53.6 | 40.998 | 15.582 |
| Gross Profit Ratio
| 0.79 | 0.79 | 0.803 | 0.803 | 0.87 | 0.87 | 0.826 | 0.826 | 0.869 | 0.869 | 0.886 | 0.875 | 0.851 | 0.851 | 0.846 | 0.794 |
| Reseach & Development Expenses
| 50.097 | 50.097 | 44.939 | 44.939 | 53.363 | 53.363 | 38.535 | 38.535 | 39.957 | 39.957 | 25.24 | 36.135 | 34.572 | 34.572 | 7.829 | 6.514 |
| General & Administrative Expenses
| 22.734 | 22.734 | 19.155 | 19.155 | 27.15 | 27.15 | 16.773 | 16.773 | 15.536 | 15.536 | 30.109 | 14.056 | 31.045 | 31.045 | 8.124 | 1.899 |
| Selling & Marketing Expenses
| 26.041 | 26.041 | 22.732 | 22.732 | 23.966 | 23.966 | 12.365 | 12.365 | 15.142 | 15.142 | 11.48 | 17.037 | 9.328 | 9.328 | 6.322 | 7.603 |
| SG&A
| 48.682 | 48.682 | 41.887 | 41.887 | 51.097 | 51.097 | 29.211 | 29.211 | 30.652 | 30.652 | 41.589 | 31.093 | 40.796 | 40.796 | 14.446 | 9.502 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.893 | 14.195 | 0 | 0 | -3.353 | 3.175 |
| Operating Expenses
| 97.317 | 97.317 | 88.501 | 88.501 | 82.433 | 82.433 | 60.006 | 60.006 | 103.031 | 103.031 | 48.936 | 81.423 | 77.947 | 77.947 | 18.922 | 19.191 |
| Operating Income
| -7.629 | -7.629 | 10.733 | 10.733 | -8.668 | -8.668 | 4.64 | 4.64 | 0.523 | 0.523 | 32.418 | -37.511 | -21.768 | -21.768 | 21.866 | -3.19 |
| Operating Income Ratio
| -0.066 | -0.066 | 0.088 | 0.088 | -0.079 | -0.079 | 0.053 | 0.053 | 0.006 | 0.006 | 0.373 | -0.704 | -0.346 | -0.346 | 0.451 | -0.163 |
| Total Other Income Expenses Net
| 3.68 | 3.68 | 0.443 | 0.443 | 28.183 | 28.183 | 11.006 | 11.006 | -30.85 | -30.85 | -0.914 | -0.583 | -3.054 | -3.054 | 0.026 | -0.507 |
| Income Before Tax
| -3.95 | -3.95 | 11.176 | 11.176 | 19.515 | 19.515 | 15.645 | 15.645 | -30.327 | -30.327 | 31.504 | -38.094 | -24.821 | -24.821 | 21.892 | -3.697 |
| Income Before Tax Ratio
| -0.034 | -0.034 | 0.092 | 0.092 | 0.177 | 0.177 | 0.178 | 0.178 | -0.371 | -0.371 | 0.363 | -0.714 | -0.394 | -0.394 | 0.452 | -0.188 |
| Income Tax Expense
| 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.097 | 0.097 | 2.944 | 2.944 | 4.024 | 1.922 | 5.955 | 5.955 | 1.502 | -0.567 |
| Net Income
| -3.941 | -3.941 | 11.185 | 11.185 | 19.523 | 19.523 | 15.548 | 15.548 | -33.271 | -33.271 | 27.48 | -40.016 | -30.575 | -30.575 | 20.438 | -3.13 |
| Net Income Ratio
| -0.034 | -0.034 | 0.092 | 0.092 | 0.177 | 0.177 | 0.177 | 0.177 | -0.407 | -0.407 | 0.316 | -0.75 | -0.486 | -0.486 | 0.422 | -0.159 |
| EPS
| -0.013 | -0.013 | 0.035 | 0.035 | 0.065 | 0.065 | 0.05 | 0.05 | -0.12 | -0.12 | 0.088 | -0.13 | -0.15 | -0.15 | 0.065 | -0.01 |
| EPS Diluted
| -0.013 | -0.013 | 0.037 | 0.037 | 0.065 | 0.065 | 0.052 | 0.052 | -0.12 | -0.12 | 0.088 | -0.13 | -0.15 | -0.15 | 0.065 | -0.01 |
| EBITDA
| -3.744 | -3.744 | 14.499 | 14.499 | -5.946 | -5.946 | 6.718 | 6.718 | 2.035 | 2.035 | 32.418 | -35.26 | -21.513 | -21.427 | 21.866 | -2.213 |
| EBITDA Ratio
| -0.032 | -0.032 | 0.119 | 0.119 | -0.054 | -0.054 | 0.077 | 0.077 | 0.025 | 0.025 | 0.373 | -0.661 | -0.342 | -0.34 | 0.451 | -0.113 |